NCT04126681 2025-03-03A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic PhaseAscentage Pharma Group Inc.Phase 2 Completed144 enrolled
NCT00413270 2011-07-13Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or IntolerantNovartisNo longer available